John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$332M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$309M |
| 3 |
Nike
NKE
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$209M |
| 5 |
Target
TGT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$238M |
| 2 |
PCGU
PG&E Corporation
PCGU
|
+$218M |
| 3 |
ConocoPhillips
COP
|
+$185M |
| 4 |
Amazon
AMZN
|
+$165M |
| 5 |
Cigna
CI
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.77% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.24% |
| 5 | Financials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Hawkins
HWKN
$2.45B
| $1.4M | ﹤0.01% |
29,372
+13,413
| +84% | +$605K |
|
|
TSP
1702
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.4M | ﹤0.01% |
843,785
-1,323,038
| -61% | -$2.14M |
|
1703
Mattel
MAT
$4.3B
| $1.4M | ﹤0.01% |
71,600
-340
| -0.5% | -$6.14K |
|
1704
Mohawk Industries
MHK
$9.09B
| $1.4M | ﹤0.01% |
13,555
-40,667
| -75% | -$3.99M |
|
|
OLO
1705
DELISTED
Olo Inc
OLO
| $1.4M | ﹤0.01% |
216,398
+24,155
| +13% | +$174K |
|
1706
TE Connectivity
TEL
$58B
| $1.4M | ﹤0.01% |
9,964
+7,756
| +351% | +$981K |
|
1707
Biohaven
BHVN
$2.17B
| $1.4M | ﹤0.01% |
+58,374
| New | +$1M |
|
1708
AAR Corp
AIR
$5.43B
| $1.4M | ﹤0.01% |
24,163
+20,263
| +520% | +$1.09M |
|
1709
GATX Corp
GATX
$6.33B
| $1.39M | ﹤0.01% |
10,827
+2,820
| +35% | +$330K |
|
1710
Cytokinetics
CYTK
$10.9B
| $1.39M | ﹤0.01% |
42,600
-172,483
| -80% | -$6.38M |
|
1711
IDT Corp
IDT
$1.71B
| $1.38M | ﹤0.01% |
53,570
+4,888
| +10% | +$151K |
|
1712
Privia Health
PRVA
$2.68B
| $1.38M | ﹤0.01% |
53,000
-63,300
| -54% | -$1.67M |
|
|
HUYA
1713
Huya Inc
HUYA
$489M
| $1.38M | ﹤0.01% |
386,405
+203,595
| +111% | +$670K |
|
1714
Daktronics
DAKT
$918M
| $1.38M | ﹤0.01% |
215,841
+129,354
| +150% | +$759K |
|
1715
Vir Biotechnology
VIR
$1.84B
| $1.38M | ﹤0.01% |
56,301
+15,314
| +37% | +$385K |
|
1716
Okta
OKTA
$22.8B
| $1.38M | ﹤0.01% |
19,900
+7,000
| +54% | +$532K |
|
1717
NovoCure
NVCR
$2B
| $1.38M | ﹤0.01% |
33,174
+12,574
| +61% | +$781K |
|
1718
Hilton Grand Vacations
HGV
$3.51B
| $1.38M | ﹤0.01% |
30,267
+3,000
| +11% | +$134K |
|
1719
German American Bancorp
GABC
$1.86B
| $1.37M | ﹤0.01% |
50,508
+21,968
| +77% | +$640K |
|
1720
CACI
CACI
$13.6B
| $1.37M | ﹤0.01% |
4,021
-47
| -1% | -$14.6K |
|
1721
CoreCivic
CXW
$3.27B
| $1.37M | ﹤0.01% |
+145,427
| New | +$1.32M |
|
1722
Avantor
AVTR
$9.71B
| $1.37M | ﹤0.01% |
66,517
-128,053
| -66% | -$2.59M |
|
|
AMK
1723
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.37M | ﹤0.01% |
46,033
+501
| +1% | +$14.7K |
|
1724
Avery Dennison
AVY
$13.7B
| $1.36M | ﹤0.01% |
7,927
-54,950
| -87% | -$9.39M |
|
1725
Bentley Systems
BSY
$11.2B
| $1.36M | ﹤0.01% |
25,100
-19,223
| -43% | -$897K |
|
Similar funds
John Overdeck's Q2 2023 Portfolio in Review
As of Q2 2023, John Overdeck held 3,452 positions worth $39.9B, up 14% from $35B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
John Overdeck deployed $2.46B of net new capital in Q2 2023, opening 521 new positions and adding to 1,149 existing holdings. Its largest new stake was Nike: 2,150,643 shares worth $237M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Netflix, an estimated $238M trimmed.
- John Overdeck's largest Q2 2023 buy was Nike: 2,150,643 shares worth $237M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $332M increase.
- John Overdeck's biggest Q2 2023 reduction was Netflix, cutting an estimated $238M.
- John Overdeck fully exited Goldman Sachs in Q2 2023, selling an estimated $127M.
- John Overdeck's ten largest holdings make up 7.6% of its $39.9B portfolio in Q2 2023.
- John Overdeck opened 521 new positions and closed 479 in Q2 2023.
- John Overdeck's portfolio value rose 14% quarter-over-quarter to $39.9B.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.